Multicenter phase Ib/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases Article

Carde, P, Timmerman, R, Mehta, MP et al. (2001). Multicenter phase Ib/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases . Journal of Clinical Oncology, 19(7), 2074-2083. 10.1200/JCO.2001.19.7.2074

Industry Collaboration International Collaboration

cited authors

  • Carde, P; Timmerman, R; Mehta, MP; Koprowski, CD; Ford, J; Tishler, RB; Miles, D; Miller, RA; Renschler, MF

sustainable development goals

authors

publication date

  • April 1, 2001

published in

keywords

  • 1ST 2
  • CELL
  • IRRADIATION
  • Life Sciences & Biomedicine
  • Oncology
  • PARTITIONING ANALYSIS RPA
  • PROGNOSTIC FACTORS
  • RADIOTHERAPY
  • RANDOMIZED CLINICAL-TRIAL
  • SENSITIZER
  • Science & Technology
  • TEXAPHYRIN
  • THERAPY-ONCOLOGY-GROUP

Digital Object Identifier (DOI)

start page

  • 2074

end page

  • 2083

volume

  • 19

issue

  • 7